会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • INSERTION MECHANISMS HAVING VENTED FLUID PATHWAYS FOR DRUG DELIVERY PUMPS
    • 插入机构具有排出的流体通道用于药物输送泵
    • WO2014011879A2
    • 2014-01-16
    • PCT/US2013/050075
    • 2013-07-11
    • UNITRACT SYRINGE PTY LTDHANSON, Ian, B.
    • HANSON, Ian, B.BENTE IV, Paul, F.O'CONNOR, Sean, M.SHAH, Jaimin, B.
    • A61M5/36
    • A61M5/36A61M5/14244A61M5/14248A61M5/158A61M5/385A61M2005/14252A61M2005/1585
    • An insertion mechanism having a vented fluid pathway includes an insertion biasing member 210, a hub 212, a needle 214, a retraction biasing member 216, and a manifold 240 having a septum 230 and a cannula 234, wherein the annular space between the septum 230 and the cannula 234 defines a manifold header 242. The manifold and fluid conduit are ventable through the membrane prior to or just after needle 214 and cannula 234 are inserted into the user. Such insertion is caused by the insertion biasing member(s) 210, after which only the needle 214 or another occlusion element is retracted. Such retraction may open a fluid pathway from the manifold header 242 to the body through the cannula 234 and/or needle 214. A drug delivery pump 10 includes such an insertion mechanism 200 having a vented fluid pathway. The drug delivery pump 10 may contain the insertion mechanism 200 having a vented fluid pathway in either an internally i or an externally tethered configuration.
    • 具有排气流体通路的插入机构包括插入偏置构件210,毂212,针214,回缩偏置构件216和具有隔膜230和套管234的歧管240, 其中隔膜230和套管234之间的环形空间限定歧管头部242.在针头214和套管234插入使用者之前或之后,歧管和流体导管可以通过膜片排出。 这种插入是由插入偏置构件210引起的,之后仅针214或另一闭塞元件缩回。 这样的缩回可以打开从歧管集管242通过套管234和/或针214到身体的流体路径。药物输送泵10包括具有排放流体路径的这种插入机构200。 药物输送泵10可以包含插入机构200,插入机构200具有内部或外部栓系结构的通气流体通路。